Juan C. Cobo-Ruiz

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

Time to Positivity of a Rapid HBsAg Assay as a Surrogate Marker of Quantitative HBsAg: Multicentre Proof-of-Concept Study.

Time to Positivity of a Rapid HBsAg Assay as a Surrogate Marker of Quantitative HBsAg: Multicentre Proof-of-Concept Study.

Journal: Alimentary pharmacology & therapeutics
Published: June 10, 2026

Clinical features and management for CDK4/6 inhibitor-DILI.

Clinical features and management for CDK4/6 inhibitor-DILI.

Journal: JHEP reports : innovation in hepatology
Published: January 29, 2026

Clinical features and management for CDK4/6 inhibitor-DILI.

Clinical features and management for CDK4/6 inhibitor-DILI.

Journal: JHEP reports : innovation in hepatology
Published: January 29, 2026

Emergency Department Screening Reveals Declining HCV Viraemia but Stable HBV Prevalence in Western Europe: A Sentinel Surveillance Opportunity.

Emergency Department Screening Reveals Declining HCV Viraemia but Stable HBV Prevalence in Western Europe: A Sentinel Surveillance Opportunity.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: January 26, 2026

Emergency department screening reveals declining HCV viraemia but stable HBV prevalence in Western Europe: A sentinel surveillance opportunity.

Emergency department screening reveals declining HCV viraemia but stable HBV prevalence in Western Europe: A sentinel surveillance opportunity.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: January 26, 2026

Unveiling pathogens and contaminants: refining metagenomics for clinical diagnostics.

Unveiling pathogens and contaminants: refining metagenomics for clinical diagnostics.

Journal: Frontiers in microbiology
Published: January 13, 2026

Current evidence of bulevirtide as monotherapy compared to combination treatment with pegylated interferon for hepatitis delta.

Current evidence of bulevirtide as monotherapy compared to combination treatment with pegylated interferon for hepatitis delta.

Journal: Expert review of anti-infective therapy
Published: October 24, 2025

Enhancing Chronic Hepatitis B and D Management Through a Tailored Mobile Health Application: Real-World Outcomes From the Adaptation of the NORA App.

Enhancing Chronic Hepatitis B and D Management Through a Tailored Mobile Health Application: Real-World Outcomes From the Adaptation of the NORA App.

Journal: Journal of viral hepatitis
Published: August 01, 2025

Beyond Risk Factors: Rethinking Hepatitis B and Hepatitis C Screening in Primary Care.

Beyond Risk Factors: Rethinking Hepatitis B and Hepatitis C Screening in Primary Care.

Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: January 20, 2025

JAK Inhibitors for Autoimmune Hepatitis: One Swallow Does Not Make a Summer.

JAK Inhibitors for Autoimmune Hepatitis: One Swallow Does Not Make a Summer.

Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: December 05, 2024

Hepatitis E as a trigger for acute-on-chronic liver failure.

Hepatitis E as a trigger for acute-on-chronic liver failure.

Journal: Clinical and molecular hepatology
Published: September 05, 2024

Enhancing linkage to care for hepatitis B, D, and C patients: A retrospective-prospective study.

Enhancing linkage to care for hepatitis B, D, and C patients: A retrospective-prospective study.

Journal: Alimentary pharmacology & therapeutics
Published: June 26, 2024
Showing 1-12 of 17

Last Updated: 09/26/2026